Objective measurement of volume of incontinent episodes · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life measurements · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects: at least one serious adverse event · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
Palliative care showed no clear difference in serious adverse events Assessed by: number of participants… compared with usual care (low certainty).
1 finding from 1 review
Intervention not reported
Sulfasalazine + prednisolone (1 RCT; 57 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes sulfasalazine + prednisolone (1 RCT; 57 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Acetazolamide versus medroxyprogesterone: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in acetazolamide versus medroxyprogesterone: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Acetazolamide + medroxyprogesterone versus medroxyprogesterone: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in acetazolamide + medroxyprogesterone versus medroxyprogesterone: risk… (low certainty).
1 finding from 1 review
Intervention not reported
Acetazolamide + medroxyprogesterone versus acetazolamide: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in acetazolamide + medroxyprogesterone versus acetazolamide: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Medroxyprogesterone versus placebo: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in medroxyprogesterone versus placebo: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Patient telephone reminder or recall · children, adolescents, and adults with a need for routine immunizations, excluding travel immunizations
The intervention probably leads to higher patient telephone reminder or recall (moderate certainty).
1 finding from 1 review
Intervention not reported
Combination of patient mail and telephone reminder or recall · children, adolescents, and adults with a need for routine immunizations, excluding travel immunizations
The intervention probably leads to higher combination of patient mail and telephone reminder or recall (moderate certainty).
1 finding from 1 review
Intervention not reported
Recurrence (within one month) · Children with pulled elbow1
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute exacerbations requiring general practitioner (GP) visit and/or additional treatment · COPD
1 finding from 1 review
Health‐related quality of life beyond one year · people with hereditary haemochromatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Composite outcome in infant (death, shoulder dystocia, nerve palsy, bone fracture) · women with gestational diabetes mellitus
It is very uncertain whether lifestyle changes composite outcome in infant (death, shoulder dystocia, nerve palsy,… compared with control ‐ Neonatal and later outcomes (very low certainty).
1 finding from 1 review
Bone mineral density · children and young adults during and after treatment for childhood cancer
1 finding from 1 review
Intervention not reported
Clinical outcome: body weight measures Multimodal/complex interventiond ATCS Plus versus usual care or control · participants at risk of developing long‐term conditions
1 finding from 1 review
Intervention not reported
Adverse outcome: unintended adverse events attributable to the intervention Multimodal/complex intervention, ATCS Plus, IVR versus various controls · participants at risk of developing long‐term conditions
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Behavioural outcome: breast cancer screening Multimodal/complex intervention versus usual care at 12 months · participants at risk for breast, colorectal or cervical cancer; or osteoporosis
The intervention leads to higher behavioural outcome: breast cancer screening Multimodal/complex… (high certainty).
1 finding from 1 review